Rituximab Treatment for Psychosis And/or Obsessive Compulsive Disorder with Probable Immune System Involvement
Rituximab Treatment for Psychosis And/or Obsessive Compulsive Disorder with Probable Immune System Involvement
Enrolling by invitation · NCT04323566 · Registry updated 2024-11-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Rituximab Treatment for Psychosis And/or Obsessive Compulsive Disorder with Probable Immune System Involvement | Psychotic Disorders, Schizophrenia Spectrum and Other Psychotic Disorders, anxiety disorder, delusional disorder, obsessive-compulsive disorder, paranoid schizophrenia, psychiatric disorder, schizophrenia | Enrolling by invitation | Phase 2 | 2024-11-19 | NCT04323566 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Uppsala University | 156 |
| Uppsala University Hospital | 80 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Uppsala University Hospital | Uppsala | Sweden | 21 |